These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)]. Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283 [TBL] [Abstract][Full Text] [Related]
5. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report. Tran TM; Browning J; Dell ML Malar J; 2006 Aug; 5():74. PubMed ID: 16925829 [TBL] [Abstract][Full Text] [Related]
6. Mefloquine for malaria chemoprophylaxis 1992-1998: a review. Schlagenhauf P J Travel Med; 1999 Jun; 6(2):122-33. PubMed ID: 10381965 [TBL] [Abstract][Full Text] [Related]
7. Paranoid psychosis related to mefloquine antimalarial prophylaxis. Fuller SJ; Naraqi S; Gilessi G P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793 [TBL] [Abstract][Full Text] [Related]
8. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration]. Meszaros K; Kasper S Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352 [TBL] [Abstract][Full Text] [Related]
9. Hallucinations and persecutory delusions in mefloquine-associated suicide. Nevin RL Am J Forensic Med Pathol; 2012 Jun; 33(2):e8. PubMed ID: 22104331 [No Abstract] [Full Text] [Related]
10. Childhood mefloquine-induced mania and psychosis: a case report. Thapa R; Biswas B J Child Neurol; 2009 Aug; 24(8):1008-9. PubMed ID: 19295181 [TBL] [Abstract][Full Text] [Related]
11. Mefloquine and malaria prophylaxis. Drug Ther Bull; 1998 Mar; 36(3):20-2. PubMed ID: 9684417 [TBL] [Abstract][Full Text] [Related]
12. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. Clattenburg RN; Donnelly CL J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947 [TBL] [Abstract][Full Text] [Related]
13. From the Centers for Disease Control. Recommendations for the prevention of malaria among travelers. JAMA; 1990 May 23-30; 263(20):2729, 2734, 2737 passim. PubMed ID: 2159078 [TBL] [Abstract][Full Text] [Related]
14. Drugs for preventing malaria in travellers. Jacquerioz FA; Croft AM Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371 [TBL] [Abstract][Full Text] [Related]
15. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Steketee RW; Wirima JJ; Slutsker L; Khoromana CO; Heymann DL; Breman JG Am J Trop Med Hyg; 1996; 55(1 Suppl):50-6. PubMed ID: 8702037 [TBL] [Abstract][Full Text] [Related]
16. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)]. Murai Z; Baran B; Tolna J; Szily E; Gazdag G Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445 [TBL] [Abstract][Full Text] [Related]
17. Acute psychosis after mefloquine. Report of six cases. Sowunmi A; Adio RA; Oduola AM; Ogundahunsi OA; Salako LA Trop Geogr Med; 1995; 47(4):179-80. PubMed ID: 8560592 [TBL] [Abstract][Full Text] [Related]